Katherine Crosby

5.8k total citations · 1 hit paper
19 papers, 2.7k citations indexed

About

Katherine Crosby is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Katherine Crosby has authored 19 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Katherine Crosby's work include PI3K/AKT/mTOR signaling in cancer (4 papers), Prostate Cancer Treatment and Research (3 papers) and Polyamine Metabolism and Applications (2 papers). Katherine Crosby is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (4 papers), Prostate Cancer Treatment and Research (3 papers) and Polyamine Metabolism and Applications (2 papers). Katherine Crosby collaborates with scholars based in United States, Canada and Australia. Katherine Crosby's co-authors include Jeffrey A. Engelman, Lecia V. Sequist, A. John Iafrate, Alice T. Shaw, Jamal Saeh, Benjamin Solomon, Balázs Halmos, Lisa Drew, Nicholas A. Jessop and John C. Wain and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer Cell.

In The Last Decade

Katherine Crosby

18 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers

2012 976 citations Ryohei Katayama, Alice T. Shaw et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by Katherine Crosby

Since Specialization

Citations

This map shows the geographic impact of Katherine Crosby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Crosby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Crosby more than expected).

Fields of papers citing papers by Katherine Crosby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Crosby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Crosby. The network helps show where Katherine Crosby may publish in the future.

Co-authorship network of co-authors of Katherine Crosby

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Crosby. A scholar is included among the top collaborators of Katherine Crosby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Crosby. Katherine Crosby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Atlanto‐occipital subluxation in an adult Thoroughbred gelding 2023 ·Equine Veterinary Education ·(unknown), Katherine Crosby, (unknown), (unknown)	0
2	Genomic delineation and description of species and within-species lineages in the genus Pantoea 2023 ·Frontiers in Microbiology ·Katherine Crosby, (unknown), Parul Sharma, (unknown), Reza Mazloom, Brian H. Kvitko, Theo H. M. Smits, Stephanus N. Venter, Teresa A. Coutinho, Lenwood S. Heath, Marike Palmer, Boris A. Vinatzer	6
3	PD-1 blockade activates conventional CD4 T cells and the innate immune response during glioblastoma eradication 2018 ·The Journal of Immunology ·Sarah R. Klein, Jennifer Ziello, Maria C. Speranza, Prafulla C. Gokhale, Paul T. Kirschmeier, Katherine Crosby, Gordon J. Freeman, David A. Reardon	4
4	From Property to Family 2014 ·University of Michigan Press eBooks ·Andrei S. Markovits, Katherine Crosby	1
5	Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer 2012 ·Cancer Research ·Hong Ren, Zhiping Tan, Xin Zhu, Katherine Crosby, Herbert Haack, Jianmin Ren, Sean A. Beausoleil, Albrecht Moritz, Gregory Innocenti, A. John Rush, Yi Zhang, Xinmin Zhou, Ting‐Lei Gu, Yifeng Yang, Michael J. Comb	92
6	PIK3CA/PTEN Mutations and Akt Activation As Markers of Sensitivity to Allosteric mTOR Inhibitors 2012 ·Clinical Cancer Research ·Funda Meric‐Bernstam, Argun Akçakanat, Huiqin Chen, Kim‐Anh Do, Takafumi Sangai, Farrell Adkins, Ana M. González-Angulo, Asif Rashid, Katherine Crosby, Mei Dong, Alexandria T. Phan, Robert A. Wolff, Sanjay Gupta, Gordon B. Mills, James C. Yao	171
7	Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers breakdown → 2012 ·Science Translational Medicine ·Ryohei Katayama, Alice T. Shaw, Tahsin Khan, Mari Mino–Kenudson, Benjamin Solomon, Balázs Halmos, Nicholas A. Jessop, John C. Wain, Alan T. Yeo, Cyril H. Benes, Lisa Drew, Jamal Saeh, Katherine Crosby, Lecia V. Sequist, A. John Iafrate, Jeffrey A. Engelman	976
8	An ErbB3 Antibody, MM-121, Is Active in Cancers with Ligand-Dependent Activation 2010 ·Cancer Research ·Birgit Schoeberl, Anthony C. Faber, Danan Li, Mei‐Chih Liang, Katherine Crosby, Matthew Onsum, Olga Burenkova, Emily Pace, Zandra E. Walton, Lin Nie, (unknown), Youngchul Song, Ulrik B. Nielsen, Jeffrey A. Engelman, Kwok‐Kin Wong	215
9	Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management. 2010 ·PubMed ·Rita Ghosh, (unknown), (unknown), (unknown), Katherine Crosby, Shylesh Bhaskaran, John Schoolfield, Jameela Banu, Gabriel da Rocha Fernandes, I‐Tien Yeh, Addanki P. Kumar	27
10	mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice 2009 ·Cancer Cell ·David A. Guertin, Deanna M. Stevens, Maki Saitoh, (unknown), Katherine Crosby, Joon-Ho Sheen, (unknown), Mark A. Magnuson, Hong Wu, David M. Sabatini	316
11	Renal tumour suppressor function of the Birt–Hogg–Dubé syndrome gene product folliculin 2009 ·Journal of Medical Genetics ·Valérie Hudon, (unknown), Anders Bondo Dydensborg, (unknown), Alexia Ghazi, Marilène Paquet, Katherine Crosby, (unknown), Noriko Uetani, Arnim Pause	88
12	Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody 2009 ·The American Journal of Surgical Pathology ·Herbert Haack, Laura A. Johnson, Christopher J. Fry, Katherine Crosby, Roberto D. Polakiewicz, Edward B. Stelow, Seung‐Mo Hong, Brian E. Schwartz, Michael J. Cameron, Mark A. Rubin, Martin C. Chang, Jon C. Aster, Christopher A. French	297
13	Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs 2008 ·RNA ·Liwei Rong, Mark Livingstone, Rami Sukarieh, Emmanuel Petroulakis, Anne‐Claude Gingras, Katherine Crosby, Bradley Smith, Roberto D. Polakiewicz, Jerry Pelletier, Maria Ferraiuolo, Nahum Sonenberg	98
14	Regulation of Cox-2 by Cyclic AMP Response Element Binding Protein in Prostate Cancer: Potential Role for Nexrutine 2007 ·Neoplasia ·Rita Ghosh, (unknown), Katherine Crosby, Hiroyasu Inoue, Ian M. Thompson, Dean A. Troyer, Addanki P. Kumar	47
15	Akt/cAMP-Responsive Element Binding Protein/Cyclin D1 Network: A Novel Target for Prostate Cancer Inhibition in Transgenic Adenocarcinoma of Mouse Prostate Model Mediated by Nexrutine, a Phellodendron Amurense Bark Extract 2007 ·Clinical Cancer Research ·Addanki P. Kumar, Shylesh Bhaskaran, (unknown), Katherine Crosby, M. Duff Davis, Peter Kochunov, John Schoolfield, I‐Tien Yeh, Dean A. Troyer, Rita Ghosh	77
16	Antibody-Based Profiling of the Phosphoinositide 3-Kinase Pathway in Clinical Prostate Cancer 2004 ·Clinical Cancer Research ·George Thomas, Steve Horvath, Bradley L. Smith, Katherine Crosby, (unknown), Matthew Schrage, Jonathan W. Said, Jean De Kernion, Robert E. Reiter, Charles L. Sawyers	54
17	The efficacy of Herceptin therapies is influenced by the expression of other erbB receptors, their ligands and the activation of downstream signalling proteins 2004 ·British Journal of Cancer ·Bradley L. Smith, D Chin, Warren Maltzman, Katherine Crosby, Gabriel N. Hortobágyi, Sarah Bacus	69
18	Imatinib-Induced Regression of AIDS-Related Kaposi's Sarcoma 2004 ·Journal of Clinical Oncology ·Henry Koon, Glenn J. Bubley, Liron Pantanowitz, David Masiello, Brad Smith, Katherine Crosby, (unknown), (unknown), Thomas E. Miller, P A Chatis, Merrill J. Egorin, Steven R. Tahan, Bruce J. Dezube	115
19	A NOVEL MONOCLONAL ANTIBODY INHIBITS THE IMMUNE RESPONSE OF HUMAN CELLS AGAINST PORCINE CELLS: IDENTIFICATION OF A PORCINE ANTIGEN HOMOLOGOUS TO CD58 2004 ·Transplantation ·Katherine Crosby, (unknown), H DerSimonian, Luying Pan, Albert S.B. Edge	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact